Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has ...

Dr. Reddy’s and Hetero partner with Gilead Sciences to manufacture and distribute Lenacapavir for HIV treatment in LMICs.

But supplies of the nation’s beloved fruit could be in jeopardy if the port strike continues for too long.By volume, the U.S.

Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment ...

Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) ...

The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...